Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Preethi Krishnan

Showing results (31-40 of 82) with videos related to

Pageof 9
Sort By:
Antimicrobial Agents and Chemotherapy|December 24, 2014
In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitorWarren Kati, Gennadiy Koev, Michelle Irvin, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvirPreethi Krishnan, Rakesh Tripathi, Gretja Schnell, et al.
Cytometry. Part B, Clinical Cytometry|September 20, 2021
Biomarkers for the clinical development of antiviral therapiesTeresa I Ng, Patrick K Dorr, Preethi Krishnan, et al.
The Journal of Infectious Diseases|April 9, 2026
Safety, Pharmacokinetics, and Pharmacodynamics of Single-Dose Programmed Cell Death Protein 1 Inhibitor, Budigalimab, in People With HIV-1 With Antiretroviral Therapy-Suppressed Viral LoadTanaya R Vaidya, Till Geib, Jacob P Lalezari, et al.
Plos One|October 5, 2018
Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvirGretja Schnell, Preethi Krishnan, Rakesh Tripathi, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
G Protein Coupled Estrogen Receptor Signaling Maintains β Cell Identity in Female MiceMadeline R McLaughlin, Preethi Krishnan, Wenting Wu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 27, 2022
Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up studyFred Poordad, Franco Felizarta, Betty B Yao, et al.
Antiviral Research|August 18, 2006
Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient seraRakesh L Tripathi, Preethi Krishnan, Yupeng He, et al.
Hepatology (Baltimore, Md.)|May 24, 2007
Identification of host genes involved in hepatitis C virus replication by small interfering RNA technologyTeresa I Ng, Hongmei Mo, Tami Pilot-Matias, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and OmbitasvirPreethi Krishnan, Gretja Schnell, Rakesh Tripathi, et al.
Pageof 9

Showing results (31-40 of 82) with videos related to

Sort By:
Pageof 9
Antimicrobial Agents and Chemotherapy|December 24, 2014
In vitro activity and resistance profile of dasabuvir, a nonnucleoside hepatitis C virus polymerase inhibitorWarren Kati, Gennadiy Koev, Michelle Irvin, et al.
Antimicrobial Agents and Chemotherapy|June 24, 2015
Resistance analysis of baseline and treatment-emergent variants in hepatitis C virus genotype 1 in the AVIATOR study with paritaprevir-ritonavir, ombitasvir, and dasabuvirPreethi Krishnan, Rakesh Tripathi, Gretja Schnell, et al.
Cytometry. Part B, Clinical Cytometry|September 20, 2021
Biomarkers for the clinical development of antiviral therapiesTeresa I Ng, Patrick K Dorr, Preethi Krishnan, et al.
The Journal of Infectious Diseases|April 9, 2026
Safety, Pharmacokinetics, and Pharmacodynamics of Single-Dose Programmed Cell Death Protein 1 Inhibitor, Budigalimab, in People With HIV-1 With Antiretroviral Therapy-Suppressed Viral LoadTanaya R Vaidya, Till Geib, Jacob P Lalezari, et al.
Plos One|October 5, 2018
Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvirGretja Schnell, Preethi Krishnan, Rakesh Tripathi, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
G Protein Coupled Estrogen Receptor Signaling Maintains β Cell Identity in Female MiceMadeline R McLaughlin, Preethi Krishnan, Wenting Wu, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|February 27, 2022
Durability of sustained virological response to glecaprevir/pibrentasvir and resistance development: A long-term follow-up studyFred Poordad, Franco Felizarta, Betty B Yao, et al.
Antiviral Research|August 18, 2006
Replication efficiency of chimeric replicon containing NS5A-5B genes derived from HCV-infected patient seraRakesh L Tripathi, Preethi Krishnan, Yupeng He, et al.
Hepatology (Baltimore, Md.)|May 24, 2007
Identification of host genes involved in hepatitis C virus replication by small interfering RNA technologyTeresa I Ng, Hongmei Mo, Tami Pilot-Matias, et al.
Antimicrobial Agents and Chemotherapy|December 9, 2015
Analysis of Hepatitis C Virus Genotype 1b Resistance Variants in Japanese Patients Treated with Paritaprevir-Ritonavir and OmbitasvirPreethi Krishnan, Gretja Schnell, Rakesh Tripathi, et al.
Pageof 9